Risheng Que
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 29
- Pancreatic and Hepatic Oncology Research 22
- Cancer Immunotherapy and Biomarkers 3
-
- Renal cell carcinoma treatment 10
- Gallbladder and Bile Duct Disorders 4
- Co-authors
- Guoping Ding (6 shared papers)Liping Cao (5 shared papers)Jionghuang Chen (1 shared paper)Shunliang Gao (25 shared papers)Tingbo Liang (21 shared papers)Xiang Li (11 shared papers)Liping Cao (3 shared papers)Xueli Bai (14 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Journal of Zhejiang University SCIENCE B (4 papers)Cancer Letters (3 papers)HPB (2 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Risheng Que
44 papers receiving 930 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 454
- Oncology 435
- Hepatology 65
- Transplantation 19
- Pulmonary and Respiratory Medicine 214
Countries citing papers authored by Risheng Que
This map shows the geographic impact of Risheng Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risheng Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risheng Que more than expected).
Fields of papers citing papers by Risheng Que
This network shows the impact of papers produced by Risheng Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risheng Que. The network helps show where Risheng Que may publish in the future.
Co-authors
The 25 scholars most cited alongside Risheng Que, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 227 | |
| 2 | 2019 | 100 | |
| 3 | 2018 | 70 | |
| 4 | 2016 | 67 | |
| 5 | 2017 | 46 | |
| 6 | 2018 | 42 | |
| 7 | 2015 | 38 | |
| 8 | 2010 | 35 | |
| 9 | 2014 | 30 | |
| 10 | 2019 | 28 | |
| 11 | 2018 | 22 | |
| 12 | 2019 | 21 | |
| 13 | 2008 | 18 | |
| 14 | 2023 | 16 | |
| 15 | 2020 | 15 | |
| 16 | 2015 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2008 | 13 | |
| 19 | 2023 | 12 | |
| 20 | 2018 | 12 |
About Risheng Que
Risheng Que is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Hepatology, having authored 45 papers that have together received 951 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (22 papers), Cancer Genomics and Diagnostics (12 papers), Renal cell carcinoma treatment (10 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Gallbladder and Bile Duct Disorders (4 papers), Neuroendocrine Tumor Research Advances (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Cancer Research (454 citations), Oncology (435 citations), Hepatology (65 citations), Transplantation (19 citations) and Pulmonary and Respiratory Medicine (214 citations). Risheng Que has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Guoping Ding, Liping Cao, Jionghuang Chen, Shunliang Gao, Tingbo Liang, Xiang Li, Liping Cao, Xueli Bai, Tao Ma and Jianying Lou. Their work appears in journals such as Journal of Clinical Oncology, Journal of Zhejiang University SCIENCE B, Cancer Letters, HPB and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.